Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SST-6006 Safety and PK in Healthy Postmenopausal Women
NCT02364882Phase 1Completed
- Sponsor
- Strategic Science & Technologies
- Start
- Jan 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sildenafil in Sexual Arousal Disorder (4 arms), sponsored by Strategic Science & Technologies. Primary endpoints: Vulvar-vaginal Irritation at 32 hours, Orthostatic Hypotension at 32 hours and 1 more. Started Jan 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on NCT02364882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364882.